Search Results - "Otoul, C."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [18F]UCB-H: First-in-Human Study by Bretin, F., Bahri, M. A., Bernard, C., Warnock, G., Aerts, J., Mestdagh, N., Buchanan, T., Otoul, C., Koestler, F., Mievis, F., Giacomelli, F., Degueldre, C., Hustinx, R., Luxen, A., Seret, A., Plenevaux, A., Salmon, E.

    Published in Molecular imaging and biology (01-08-2015)
    “…Purpose [ 18 F]UCB-H is a novel radiotracer with a high affinity for synaptic vesicle glycoprotein 2A (SV2A), a protein expressed in synaptic vesicles. SV2A is…”
    Get full text
    Journal Article Web Resource
  2. 2

    Long-term continuation of levetiracetam in patients with refractory epilepsy by KRAKOW, Karsten, WALKER, M, OTOUL, C, SANDER, J. W. A. S

    Published in Neurology (26-06-2001)
    “…The long-term continuation (retention) rate, efficacy, and safety data of the new antiepileptic drug levetiracetam (LEV) was evaluated in all patients with…”
    Get full text
    Journal Article
  3. 3

    Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy by Otoul, Christian, Arrigo, Celestina, van Rijckevorsel, Kenou, French, Jacqueline A

    Published in Clinical neuropharmacology (01-03-2005)
    “…Few comparative clinical trials of newer antiepileptic drugs (AEDs) in patients with refractory partial epilepsy are available. Therefore, meta-analysis is a…”
    Get full text
    Journal Article
  4. 4

    Dose–response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy by Boon, P, Chauvel, P, Pohlmann-Eden, B, Otoul, C, Wroe, S

    Published in Epilepsy research (2002)
    “…Purpose: To evaluate the efficacy, dose–response, tolerability, and withdrawal effects of levetiracetam (Keppra®) as adjunctive therapy in adult patients with…”
    Get full text
    Journal Article
  5. 5

    Comparison of plasma and saliva concentrations of levetiracetam following administration orally as a tablet and as a solution in healthy adult volunteers by Lins, R L, Otoul, C, De Smedt, F, Coupez, R, Stockis, A

    “…Concentrations in saliva, as an alternative to concentrations in blood, can be advantageous for the monitoring of antiepileptic agents. This study assesses the…”
    Get full text
    Journal Article
  6. 6

    Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers by PEYTAVIN, G, GAUTRAN, C, OTOUL, C, CREMIEUX, A. C, MOULAERT, B, DELATOUR, F, MELAC, M, STROLIN-BENEDETTI, M, FARINOTTI, R

    Published in European journal of clinical pharmacology (01-06-2005)
    “…Serious adverse effects have been observed with some non-sedative H1-antihistamines (terfenadine and astemizole) when they were associated with drugs known to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    90 Safety, efficacy and transcriptional changes following repeated administration of dapirolizumab pegol in patients with systemic lupus erythematosus: results from a phase i study by Chamberlain, C, Colman, P, Ranger, A, Johnson, G, Otoul, C, Stach, C, Dörner, T, Urowitz, M, Hiepe, F

    Published in Lupus science & medicine (01-03-2017)
    “…Background and aimsBinding of CD40 ligand (CD40L) to CD40 activates B cells, antigen-presenting cells and platelets. Evidence suggests CD40L blockade might…”
    Get full text
    Journal Article
  9. 9

    Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: A pooled analysis of data from randomized clinical trials by Gidal, Barry E., Baltès, Eugène, Otoul, Christian, Perucca, Emilio

    Published in Epilepsy research (01-03-2005)
    “…The purpose of this study was to determine the influence of levetiracetam on the steady-state serum concentrations of other commonly used antiepileptic drugs…”
    Get full text
    Journal Article
  10. 10
  11. 11

    PI-45 by Otoul, C., De Smedt, H., Stockis, A.

    Published in Clinical pharmacology and therapeutics (01-02-2006)
    “…BACKGROUND To assess levetiracetam (LEV) add‐on treatment effect on plasma concentrations of other antiepileptic drugs (AEDs) in paediatrics with epilepsy…”
    Get full text
    Journal Article
  12. 12

    The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy by Bell, Caroline, Vanderlinden, Hilde, Hiersemenzel, Reinhard, Otoul, Christian, Nutt, David, Wilson, Sue

    Published in Journal of sleep research (01-09-2002)
    “…Summary Levetiracetam is a novel antiepileptic drug which has recently been released as an adjunctive treatment for partial epilepsy. In the two studies…”
    Get full text
    Journal Article
  13. 13
  14. 14

    PIII-81 by Ramael, S., Troenaru, M., Toublanc, N., Daoust, A., Otoul, C., Lu, Z., Stockis, A.

    Published in Clinical pharmacology and therapeutics (01-02-2006)
    “…BACKGROUND The primary objective was to evaluate the safety, tolerability and pharmacokinetics of levetiracetam (LEV) administered intravenously at a higher…”
    Get full text
    Journal Article
  15. 15